Neuralink, led by Elon Musk, opens recruitment for initial Human experiments

Elon Musk's venture, Neuralink, invites human volunteers to participate in trials involving its innovative N1 brain-computer interface. The groundbreaking study, named PRIME (Precise Robotically Implanted Brain-Computer Interface), is particularly interested in participants with quadriplegia resulting from cervical spinal cord injuries or amyotrophic lateral sclerosis (ALS). Applicants should be at least 22 years old and have a dedicated and trustworthy caregiver.

Musk mentioned in 2022 his plans to implant the device in his brain. However, it's doubtful he will be in the initial group of test subjects. Founded in 2016, Neuralink's mission is to bridge the human brain with computer technology, potentially allowing those with neurological disorders to interface directly with devices. For instance, someone with paralysis might operate their smartphone through mere thought. Musk envisions a future where this technology offers "superhuman cognition."

But first, the PRIME study aims to gauge the safety and effectiveness of the N1 implant and the R1 surgical robot. The ultimate objective is to empower paralytic patients to manipulate external devices using their thoughts. According to Neuralink's website, the study will utilize the R1 robot to implant the N1 device's delicate threads into the brain region responsible for movement intention. Once established, the implant will be unnoticeable and wirelessly relay brain signals to an app deciphering movement intentions. The initial goal is to allow individuals to control computer cursors or keyboards with their thoughts.

Endorsed by the FDA's investigational device exemption (IDE) in May, the PRIME study marks a crucial advancement in Neuralink's journey to create a universal brain interface that restores autonomy to those with specific medical needs.

Last year, Neuralink showcased a monkey using the interface to play Pong with its thoughts and control a computer cursor similarly. The company's use of animals in research has drawn criticism despite their commitment to ethical treatment. Musk recently refuted allegations about the mortality rate of monkeys with the implant, clarifying that no deaths resulted from Neuralink procedures.

While Neuralink is pioneering in its field, others, like BrainGate, have introduced comparable technologies, like enabling a paralyzed man to convert imagined handwriting into text.

It's an exciting phase for Neuralink, and many are optimistic about the transformative potential of its technology – not only for those with paralysis but perhaps even in realizing Musk's broader aspirations.